DRUG · Mapped RxNorm record
iloprost
Normalized identity: iloprost View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
NCT00084409
Study summary
ClinicalTrials.govIloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
iloprostDRUG · verified · RxNorm: iloprost
placeboOTHER
Sponsors & collaborators
University of Colorado, Denverlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00084409 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.